Delirium, Dementia, Amnestic, Cognitive Disorders  >>  atabecestat (JNJ-54861911)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
atabecestat (JNJ-54861911) / J&J
NCT01978548: A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Completed
1
45
Europe
JNJ-54861911 10 mg, JNJ-54861911 50 mg, Placebo
Janssen Research & Development, LLC
Alzheimer Disease
04/15
04/15

Download Options